Thursday, July 17, 2014

Partnerships Asia Session Spotlight: Clinical Trial Design and Compliance – Medical Devices vs. Pharmaceuticals

In 2011 in the United States alone, there was between $95 and $105 billion spent on medical devices.  This is a significant amount of the $200 billion that was spent worldwide on these devices according to chireco.com.  How are medical devices defined in the United States?
  • - Diagnoses, cures, lessens, treats, or prevents disease
  • - Affects the function or structure of the body
  • - Does not achieve primary intended purposes through chemical action
However, regulations across different countries present different rules and regulations for clinical trials across the world.  This September at Partnerships in Clinical Trials Asia, we'll be looking at how these devices are defined and conducted in Asia.

Featured Presentation: Clinical Trial Design and Compliance – Medical Devices vs. Pharmaceuticals
Featured Presenter: Timothy Low, Vice President, Medical Affairs Asia Pacific, Covidien, Singapore
About the session: 
  • - Examining the differences between medical device and pharmaceutical trials
  • - What are the medical device trial design considerations?
  • - Compliance – GCP vs. ISO14155
Partnerships in Clinical Trials Asia will take place this September 16-18 in Shanghai, China.  For more information on this session, download the agenda.  As a reader of this blog, when you register to join us and mention code XP1975BLOG, you'll save 20% off the standard rate.




No comments: